CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 

Johnson & Johnson  (JNJ)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Johnson & Johnson

JNJ's Financial Statements and Analysis




       
 
Johnson & Johnson reported in III. Quarter net earnings per share of $1.53 an increase by 0 % year on year from $1.20 and an improvement of 0 % from $1.43 realized in II. Quarter (Jul 03 2016).

More on JNJ's Income Statement

   
     

       
 
III. Quarter
Earnings Per Share Revenues
$ 1.53 $  17,820 Mill
$+0.33     +27.5 % $+718M     +4.2 %
   
     
       
     
     

       
  Johnson & Johnson's Revenue rose by 4.2 % in III. Quarter (Oct 02 2016) year on year, to $17,820 million and declined by -3.58 % sequentially.

More on JNJ's Growth

   
     

Johnson & Johnson is Expected to report next financial results on April 13, 2017.

       
  • PROCRIT 77.52% Y/Y,
• RISPERDAL 76.41% Y/Y,
• REMICADE 83.39% Y/Y,
• VELCADE 75.58% Y/Y,
• CONCERTA 218.52% Y/Y,
• INVEGA 105.77% Y/Y
   
     
       
  • Other -2.12% Y/Y,
• Total Pharmaceutical -4.35% Y/Y,
• Med. Dev. & Diag. -3.24% Y/Y,
• Nutritionals -4.42% Y/Y,
• Skin Care -2.83% Y/Y,
• Total Consumer -2.95% Y/Y
   
     


  • JNJ's Segments
       
 
You need to upgrade your Flash Player


More on JNJ's EPS
   
     
       
  JNJ's NET INCOME
Johnson & Johnson's net income of $4,272 million in III. Quarter increased by 27.22 % from net earnings of $3,358 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 6.88 % from net income of $3,997.00 million realized in previous quarter.

More on JNJ's Growth
   
     


       
  • Total Pharmaceutical 39.91% Y/Y,
• Total Consumer 232.92% Y/Y
   
     
       
  • Med. Dev. & Diag. -11.36% Y/Y    
     

Inventories JNJ's Cash flow
Inventories grew by 3.44 % to $8,488 million from III. Quarter a year ago, sequentially inventories fell by -0.41 %.

More on JNJ's Balance Sheets
In III. Quarter company's net cash and cash equivalents decreased by $-435 million, capital expenditures fell by -192.59%, to $-737 millions compare to same quarter a year ago and rose by -2.64% from II. Quarter (Jul 03 2016).

More on JNJ's Cash flow Statement
       
 
Johnson & Johnson payed out dividend of $3.10 per share in last 52 weeks representing 54.87 % of net earning per share in trailing twelve-month period.

During the same period Johnson & Johnson earned $ 6.11 cash per share, on a free-cash flow basis 108.2 % of net earning per share.

Book value grew by 0.73 % sequentially to $26.13 per share, 11.26% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 7.88 per share from $ 8.83.

Company repurchased 8.80 million shares or 0.31 % in III. Quarter.
Interest Coverage Ratio was 28.4. Debt Coverage Ratio was 0.83.

More on JNJ's Dividends

   
     
       
 
 Market Capitalization (Millions $) 317,285
 Shares Outstanding (Millions) 2,785
 Total Debt (Millions $) 26,989
 Revenue (TTM) (Millions $) 71,595
 Net Income (TTM) (Millions $) 15,776
 Cash Flow (TTM) (Millions $) 4,566
 Capital Exp. (TTM) (Millions $) -3,499
 Dividend TTM ($) 3.1 $
 Dividend Yield TTM (%) 2.81 %
 Employees (TTM) $ 126,500
   
     
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
SPAN's Profile
Stock Price
SPAN's Financials
SPAN's Expectations
Business Description
Fundamentals
Charts & Quotes
SPAN's News
Suppliers
SPAN's Competitors
Customers & Markets
Economic Indicators
SPAN's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com